NEW YORK CITY More than a dozen world-class research institutions, along with business leaders and the investment community have joined the City and State of New York to launch the New York City Bioscience Initiative. Access to Resources New York City provides unparalleled access to an unmatched aggregation of resources. Renowned research institutions, top scientific talent, investment capital and professional services make up New York City’s thriving Bioscience community. Accessible to global markets from three major airports, the city is the location of choice for over 112 bioscience companies — everything from early stage drug discovery companies to pharmaceutical giants such as Pfizer.
Access to Research Leading Academic Medical Centers New York City institutions are national leaders in research and NIH grants. Top-ranked programs include Cornell, Columbia, NYU, Hospital for Special Surgery, Mt. Sinai, Rockefeller and Albert Einstein. The City is home to five of the top medical schools for research, nine Academic Medical Centers and more Howard Hughes investigators than any other city. A Vibrant R&D Community New York City’s vibrant and established academic bioscience community receives annual R&D expenditures approaching $1.9 billion and the City is one of highest ranked for NIH funding. New York City is the right place for clinical trials, with its incredibly large and ethnically diverse population. Fifty percent of all oncology trials are conducted here. Access to Talent World Class Scientific and Medical Talent Bioscience companies in New York City have access to an unmatched pool of scientific and medical talent. Employing almost 30,000 physicians and a bioscience workforce of 110,000, the metro area has more scientific talent than Boston, San Diego and San Francisco combined. New York City is also training the next generation of scientific talent and is home to more life sciences graduate students than any other city and more bioscience and engineering graduates than most states.